BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6505626)

  • 1. Range and clinical significance of the number of myeloid-committed stem cells in the blood of patients with acute leukaemia in remission.
    Hinterberger W; Bettelheim P; Höcker P; Lechner K; Neumann E; Niessner H
    Scand J Haematol; 1984 Sep; 33(3):244-51. PubMed ID: 6505626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a novel prognostic factor for predicting short survival.
    Sagaster V; Ohler L; Berer A; Kabrna E; Ofner P; Lechner K; Geissler K
    Ann Hematol; 2004 Jan; 83(1):9-13. PubMed ID: 13680175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?
    Jansen EM; Hanks SG; Terry C; Akard LP; Thompson JM; Dugan MJ; Jansen J
    Transfusion; 2007 May; 47(5):817-23. PubMed ID: 17465946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CFU-mix are no better than CFU-GM in predicting hemopoietic reconstitutive capacity of peripheral blood stem cells collected in the very early remission phase of acute nonlymphoblastic leukemia.
    To LB; Dyson PG; Branford AL; Haylock DN; Kimber RJ; Juttner CA
    Exp Hematol; 1987 May; 15(4):351-4. PubMed ID: 2883016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of the S-phase fraction of myeloid-determined stem cells (CFU-GM) using the cytosine arabinoside suicide technic in patients with acute myeloid leukemia in complete remission following polychemotherapy].
    Goldschmidt H; Elstner E; Wulsche H; Wächter M; Ihle R
    Arch Geschwulstforsch; 1987; 57(5):385-92. PubMed ID: 3479950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colony formation of CFU-MK and other hemopoietic progenitors in patients with acute non-lymphoblastic leukemia at diagnosis and following complete remission.
    Chen Y; Li P; Lin B; Zhang G; Ruan C
    Nouv Rev Fr Hematol (1978); 1989; 31(3):183-6. PubMed ID: 2616265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CFU-gm colony formation of peripheral blood and bone marrow in adult acute leukemia at presentation, during remission, and at relapse.
    Jehn U; Wachholz K
    Int J Cell Cloning; 1985 Jul; 3(4):199-213. PubMed ID: 3860564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between blood granulocyte progenitor cells and polymorphonuclear leukocytes. A tentative pathophysiological subgrouping of neutropenic and neutrophilic patients.
    Ponassi A; Morra L; Mela GS; Caristo G; Parodi GB; Sacchetti C
    Biomed Pharmacother; 1983; 37(6):293-7. PubMed ID: 6671134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
    Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro proliferation of hematopoietic stem cells circulating in blood of patients with kidney allografts.
    Górski A
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):969-73. PubMed ID: 373694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of monoclonal antibodies in the antigenic characteristics of normal myeloid progenitor cells and clonogenic blasts in acute myeloid leukaemia.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1988; 36(1):71-84. PubMed ID: 3233065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation.
    Takamatsu Y; Harada M; Teshima T; Makino S; Inaba S; Akashi K; Shibuya T; Niho Y
    Exp Hematol; 1995 Jan; 23(1):8-13. PubMed ID: 7527786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collection of circulating stem cells and their use for autograft in adults with acute lymphoblastic leukaemia.
    Hénon P; Debecker A; Lepers M; Eisenmann JC; Kandel G; Dorr R; Selva J
    Nouv Rev Fr Hematol (1978); 1988; 30(4):229-35. PubMed ID: 3057436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.
    Gordon MY; Marley SB; Lewis JL; Davidson RJ; Nguyen DX; Grand FH; Amos TA; Goldman JM
    J Clin Invest; 1998 Aug; 102(4):710-5. PubMed ID: 9710439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
    Janikova A; Koristek Z; Vinklarkova J; Pavlik T; Sticha M; Navratil M; Kral Z; Vasova I; Mayer J
    Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
    Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
    Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating colony-forming cells in different stages of chronic myelocytic leukemia.
    Leong SS; Sokal JE; Gomez GA; Horoszewicz JS
    Cancer Res; 1979 Jul; 39(7 Pt 1):2704-10. PubMed ID: 286638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.